Clinical Trials Directory

Trials / Unknown

UnknownNCT04150003

Study on the Effect of a Physical Training Structured Program After a Pulmonary Thromboembolism

Multicenter, Randomize Study to Evaluate the Effect of a Physical Training Structured Program After a Pulmonary Thromboembolism in the Restoration Lung Perfusion

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
144 (estimated)
Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Exercise training, as the core component of a Pulmonary Rehabilitation program, may help restore arterial blood flow in the lungs of patients who had suffered Pulmonary Embolism (PE), stimulating and promoting vasodilator effects, repairing the damaged endothelium and recruiting new blood vessels and also inducing a net fibrinolytic balance. Besides, exercise training could have a positive effect on quality of life of these patients.

Detailed description

An experimental multicenter study is proposed , randomized according to parallel assignation and blinded to third ones to evaluate the effect of a 10-weeks structured exercise-based intervention protocol on the restoration of lung blood flow after an acute PE. Main objective is to compare the efficacy and safety in terms of quantitative measures from lung scintigraphy, of lung perfusion versus usual care in patients with PE. Additionally the study is aimed to identify bio-markers of response to treatment (mRNAs, MPs and proteomic approach) and to analyze the effects of training on exercise capacity, quality of life parameters and anxiety depression scores.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPulmonary Rehabilitation programStructured rehabilitation program of directed exercises
OTHERUsual careUsual care for patients who had suffered a Pulmonary Embolism

Timeline

Start date
2019-11-01
Primary completion
2021-11-01
Completion
2022-01-01
First posted
2019-11-04
Last updated
2021-01-14

Locations

3 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT04150003. Inclusion in this directory is not an endorsement.